| Date | Title | Description |
| 12.03.2024 | Synspective’s small SAR satellite “StriX-3” successfully entered orbit. Successful deployment of the antenna was also confirmed. | Synspective Co., Ltd.
Synspective’s small SAR satellite “StriX-3” successfully entered orbit. Successful deployment of the antenna was also confirmed. ……
Synspective Co., Ltd. (Headquarters: Koto-ku, Tokyo; Representative Director and CEO: ... |
| 26.02.2024 | ROTC Cadets Learn Valuable Life Lessons from African American Military Leaders at NC ROTC Roundtable | FOR IMMEDIATE RELEASE
Date: Thursday, February 22, 2024
Contact: Tammy Martin
Office: 984-292-3255
Cell: 984-480-6256 tammy.martin@milvets.nc.gov
ROTC Cadets Learn Valuable Life Lessons from African American
Military Leaders at NC ROTC Roun... |
| 20.02.2024 | Adverse Event Prompts FDA Hold on Tests of Drug in Atopic Dermatitis & Asthma | Rapt Therapeutics aim to bring patients oral alternatives to injectable or infused immunology medications has hit a setback. A Rapt drug candidate in mid-stage clinical development in atopic dermatitis and asthma has been placed under an FD... |
| 11.02.2024 | This Biotech Startup Just Raised $105M to Extinguish Inflammation at the Source | Inflammation is like a fire you just can’t put out—inflammatory disorders are chronic conditions after all. If your house is ablaze and you know a gas leak is the cause, dousing the entire home isn’t a targeted way to stop what’s feeding th... |
| 02.02.2024 | Neuro Biotech Alto Adds $128M in IPO Cash for Biomarker-Based Psych Drugs | Matching a patient to a drug according to the patient’s biology is not a new idea, but it hasn’t caught on in neuropsychiatric disorders, which have high failure rates in drug studies. The technology of Alto Neuroscience brings precision me... |
| 22.01.2024 | Deals in brief: Elon Musk denies claims of xAI securing USD 500 million, Tumodo raises USD 35 million, 12 China and India deals, and more | Elon Musk denies claims of xAI securing USD 500 million
On January 20, Bloomberg reported that xAI, an artificial intelligence company founded by Elon Musk in March 2023, has secured USD 500 million in commitments from investors toward a US... |
| 17.01.2024 | Cell Therapy Startup With Stanford Roots Unveils $75M to Seek Inflammation Cures | When immune cells go awry and spark inflammation, a different type of immune cell stands ready to counteract that effect and return the immune system to a state of balance. Therapies based on such cells are part of an emerging area of resea... |
| 16.01.2024 | Allakos Skin Drug Fails 2 Mid-Stage Tests, Sparks Restructuring to Cut 50% of Staff | The lead therapeutic candidate of Allakos has failed in two mid-stage clinical trials for inflammatory skin disorders, leading the biotech to halt work on the drug. Allakos is shifting its focus to an earlier-stage program in its pipeline b... |
| 15.01.2024 | Genetic Medicines Biotech Dyne Pulls In $345M for Clinical Tests of Muscle Drugs | Dyne Therapeutics started the new year with proof-of-concept clinical data for experimental genetic medicines addressing two rare muscle diseases—one of which has no FDA-approved treatments. Now the biotech has $345 million as it looks towa... |
| 02.01.2024 | Longboard Pharma Trial Data Show How It Could Stand Out in the Epilepsy Field | Longboard Pharmaceuticals is chasing much bigger companies already in the market with therapies for rare forms of epilepsy. The biotech has gone from saying its drug could be differentiated to claiming it has best-in-class potential. Longbo... |
| 19.12.2023 | Chiesi Rare Skin Disease Drug Acquired in Billion Dollar Deal Wins FDA Approval | The rare inherited disorder epidermolysis bullosa, or EB, leads to skin so fragile that it tears like tissue paper. The resulting wounds and blisters are slow to heal and prone to infection. On Tuesday, the FDA approved a Chiesi Group drug ... |
| 11.12.2023 | On Heels of ASH Data, Pfizer Eyes FDA Submission for New Hemophilia Drug | Patients with hemophilia A or B can manage the inherited bleeding disorders with regular infusions of the clotting proteins they lack. This treatment helps—until it doesn’t. One problem with these infused factor replacement therapies is pat... |
| 09.12.2023 | FDA Approves Not One, But Two Sickle Cell Disease Gene Therapies | Gene therapy is now here for patients with sickle cell disease. The FDA on Friday approved treatments from Vertex Pharmaceuticals and Bluebird Bio, each offering a potentially curative treatment for the inherited blood disorder.
Approval fo... |
| 07.12.2023 | WWII MIA, Second Lieutenant FRED BREWER laid to rest at Salisbury National Cemetery | FOR IMMEDIATE RELEASE
Date: Wednesday, December 6, 2023
Contact: Tammy Martin
Office: 984-292-3255
Cell: 984-480-6256 tammy.martin@milvets.nc.gov
WWII MIA, Second Lieutenant FRED BREWER laid to rest at
Salisbury National Cemetery
U.S. Army ... |
| 20.11.2023 | Carmot’s IPO Filing Makes Case for Bias in Drugging Key Obesity, Diabetes Targets | Carmot Therapeutics is catching up to companies with drugs designed to hit receptors that have become hot targets for metabolic diseases such as diabetes and obesity. But clinical-stage Carmot believes its approach offers a better way of dr... |
| 06.11.2023 | CCI France Malaysia Gala Night 2023, celebrating Malaysia France bilateral trade at a record height of €6.2 billion or MYR28.5 billion in 2022 | KUALA LUMPUR, Malaysia, Nov. 6, 2023 /PRNewswire/ -- The Malaysian French Chamber of Commerce & Industry / CCI France Malaysia (CCIFM) held its Gala Night on 2nd November 2023 in JW Marriott Kuala Lumpur celebrating the business relatio... |
| 03.10.2023 | Eli Lilly Jumps Into Radiopharmaceuticals via $1.4B Point Biopharma Acquisition | Eli Lilly’s scope in cancer is expanding to radiopharmaceuticals with the $1.4 billion acquisition of Point Biopharma Global, a company in late-stage clinical development with two programs, one of which could challenge a fast growing produc... |
| 29.08.2023 | The wild life of billionaire Twitter cofounder Jack Dorsey, who is known for eccentricities like eating one meal a day and taking ice baths | Tech The wild life of billionaire Twitter cofounder Jack Dorsey, who is known for eccentricities like eating one meal a day and taking ice baths
Grace Kay
2023-08-29T10:07:00Z
Share icon An curved arrow pointing right.
Share
Facebook Icon T... |
| 13.08.2023 | VC Report: Biotech Financings Fall, M&A Activity Expected to Pick Up | Venture capital is available, but the trending numbers do not favor startups. Deal counts have plateaued and deal sizes are down from the recent peak in 2021. These market conditions are leading startups to change their strategies in order ... |
| 07.08.2023 | Astellas Drug Acquired in $5.9B Deal Wins FDA Approval in Vision-Loss Disorder | An Iveric Bio drug at the heart of a $5.9 billion Astellas Pharma acquisition has received FDA approval, making it just the second approved therapy for a common vision loss-disorder that afflicts an estimated 1.5 million people in the U.S.
... |
| 01.08.2023 | Neon lands $46M for its serverless Postgres database management system
Easing the developer’s burden
Your vote of support is important to us and it helps us keep the content FREE.
One-click below s... | Neon Inc. a two-year-old startup that’s building a serverless version of the open-source Postgres database management system, said today that it has raised $46 million in Series B funding, bringing its total fundraising to $104 million.
Pos... |
| 27.07.2023 | FDA Refuses to Review Biohaven Drug for Rare Neuromuscular Disease With No Treatments | Biohaven acknowledges its experimental drug for spinocerebellar ataxia failed in a pivotal study, but the biotech hoped results showing benefit in a subgroup would be enough to secure approval for those patients given that this rare, inheri... |
| 21.07.2023 | Biden-Harris Administration Hosts Inaugural Asian American, Native Hawaiian, and Pacific Islander Mental Health Summit | Mental health professionals, federal policymakers, and community leaders gather to advance equity and improve access to behavioral health care for AA and NHPIs.
Historic event builds on President Biden’s Mental Health Strategy and the Admin... |
| 19.07.2023 | Update No. 4: Chief Medical Examiner’s Office rules Rutland police officer’s death a homicide | STATE OF VERMONT
DEPARTMENT OF PUBLIC SAFETY
VERMONT STATE POLICE
Chief Medical Examiner's Office rules Rutland police officer's death a homicide
RUTLAND, Vermont (Wednesday, July 19, 2023) — The Vermont Chief Medical Examiner's Office has ... |
| 09.07.2023 | Update No. 3: Charges filed in crash that killed Rutland police officer | STATE OF VERMONT
DEPARTMENT OF PUBLIC SAFETY
VERMONT STATE POLICE
Charges filed in crash that killed Rutland police officer
RUTLAND, Vermont (Saturday, July 8, 2023) — Initial charges have been filed against the man who led Rutland police o... |
| 30.06.2023 | NBRPA AND DALLAS CHAPTER BRING FULL COURT PRESS PROGRAM TO DALLAS, TEXAS | NBRPA
NBRPA - Full Court Press - Dallas
- LEGENDS LED LOCAL YOUTH FROM DALLAS POLICE DEPT. OUTREACH GROUP IN BASKETBALL ACTIVITIES AND LIFE SKILLS CURRICULUM -
CHICAGO, ILLINOIS, UNITED STATES, June 30, 2023/EINPresswire.com/ -- The Nationa... |
| 30.06.2023 | NBRPA AND CLEVELAND CHAPTER TEAM UP TO BRING FULL COURT PRESS PROGRAM TO “THE LAND” | NBRPA
NBRPA - FCP - Cleveland
- LEGENDS LED CLEVELAND RECREATION CENTERS YOUTH IN BASKETBALL ACTIVITIES AND LIFE SKILLS CURRICULUM -
CHICAGO, ILLINOIS, UNITED STATES, June 30, 2023/EINPresswire.com/ -- The National Basketball Retired Player... |
| 27.06.2023 | UCB Muscle Disease Drug Wins FDA Nod on Heels of Rival’s Regulatory Approval | The available drugs for generalized myasthenia gravis address only patients whose disease exhibits a particular biological profile. The FDA has approved a new UCB drug that encompasses those covered by current treatments as well as an addit... |
| 15.06.2023 | Bleeding Problems Prompt FDA Partial Hold on Tests of Mersana Cancer Drug | Bleeding complications, some of them fatal, have been reported in clinical tests of an experimental Mersana Therapeutics ovarian cancer drug, prompting the FDA to pause enrollment in two studies. The setback comes three months after a fatal... |
| 04.06.2023 | In Key Study, Servier Drug Delays Brain Cancer in Patients With Few Treatment Options | In the brain cancer known as a diffuse glioma, the disease infiltrates the central nervous system causing cognitive and physical disability. But the limited treatment options available bring about cognitive problems too. An experimental dru... |
| 30.05.2023 | Pfizer Hemophilia Drug Reduces Bleeding in Key Study; Regulatory Filings Are Planned | An experimental Pfizer hemophilia drug that takes a new approach to treating the blood clotting disorder has met the main goal of a pivotal study, setting the stage for regulatory submissions planned for later this year.
The drug, marstacim... |
| 18.05.2023 | EyePoint Pharma Sells U.S. Rights to Eye Med to Become Pure Play Drug Developer | EyePoint Pharmaceuticals has commercialized products, but the eye therapies maker wants to focus on its pipeline, including a lead program in mid-stage clinical development for two serious eye disorders. To achieve this goal, the company ha... |
| 12.05.2023 | Sobi Emerges as Savior for CTI Biopharma Cash Crunch With $1.7B M&A Deal | CTI Biopharma has something many biotech companies aspire to achieve—revenue. Sales of its approved cancer drug are growing, but commercialization comes with costs as does development of the molecule for additional indications. CTI expects ... |
| 02.05.2023 | Delaware Forest Service Celebrates Arbor Day With Tree Planting | DOVER, Del. (May 2, 2023) – On the morning of Saturday, April 29, the Delaware Forest Service celebrated Arbor Day with an extensive tree planting surrounding the Peters Scout Camp/Peters Tract at Blackbird State Forest, along with our 2023... |
| 02.05.2023 | Travere Therapeutics Drug for Rare Kidney Disease Falls Short in Pivotal Test | When Travere Therapeutics initially fell short of providing sufficient clinical data to support an application seeking accelerated drug approval in a rare kidney disorder, the FDA told the biotech last year that carrying out a Phase 3 study... |
| 02.05.2023 | J&J Expands in Cancer, Paying $245M for Two Next-Generation Cell Therapies | Johnson & Johnson’s first cancer cell therapy came via a licensing agreement. Dealmaking is bringing two more to its pipeline. The pharmaceutical giant has agreed to pay Cellular Biomedicines $245 million for two next-generation cell th... |
| 01.05.2023 | Eying Its Next Blockbuster, Astellas Lines Up $5.9B Iveric Bio Acquisition | Astellas Pharma is hunting for drugs to make up for the decline in revenue facing its top-selling product as it loses patent protection in the next few years. It sees a strong contender in an Iveric Bio drug candidate for a common vision lo... |
| 26.04.2023 | Orbital Therapeutics Raises $270M to Bring RNA-Based Medicines to New Heights | RNA research has come a long way, leading to commercialized vaccines and a growing list of therapies in development. But this work just scratches the surface of how RNA can transform medicine, according to Giuseppe Ciaramella, co-founder an... |
| 24.04.2023 | The Public Health Emergency Is Expiring, So What Is the Future of Covid-19 Vaccines? | Covid-19 sent the biotech industry into overdrive to develop vaccines that could tame the novel coronavirus. In relatively short order, and after different kinds of vaccines were researched, we have reached a state where the vast majority o... |
| 14.04.2023 | DIDD Partners with DCS to Provide Residential Care for Hospitalized Children | NASHVILLE—As a part of Gov. Bill Lee’s TN Strong Families initiative, the Department of Intellectual and Developmental Disabilities (DIDD) has started serving children in DCS custody with intellectual and developmental disabilities who have... |
| 13.04.2023 | Snowflake’s newest industry cloud targets manufacturers
Improved visibility
Partner-led
Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the comm... | Snowflake Inc. today is rolling out its sixth industry-specific offering, this one targeting manufacturers.
The Manufacturing Data Cloud is aimed at supporting companies in the automotive, technology, energy and industrial sectors in addres... |
| 10.04.2023 | FDA Partial Hold on Cancer Drug Adds to Molecular Templates’ Growing List of Woes | A Molecular Therapeutics cancer drug candidate, one of the surviving programs of a recent corporate shakeup that slashed the company’s workforce in half, is now on pause. The FDA is asking for more information about two patients whose cardi... |
| 06.04.2023 | DIDD Partners with DCS to Provide Residential Care for Hospitalized Children | NASHVILLE—As a part of Gov. Bill Lee’s TN Strong Families initiative, the Department of Intellectual and Developmental Disabilities (DIDD) has started serving children in DCS custody with intellectual and developmental disabilities who have... |
| 31.03.2023 | Cytokinetics Stops ALS Program After Analysis Finds No Evidence of Effect | Cytokinetics will stop further testing of its experimental amyotrophic lateral sclerosis drug after an early look at the data found it was unlikely to succeed. The result comes four years after the Cytokinetics drug flunked its mid-stage te... |
| 28.03.2023 | Novartis Puts Up $50M to Steer Bicycle Therapeutics’ Tech Into New Cancer Meds | Bicycle Therapeutics’ novel approach to developing peptide drugs has produced several cancer clinical-stage drug candidates. Now Novartis wants to see if this technology can lead to better radiopharmaceuticals.
According to terms of a new p... |
| 26.03.2023 | FDA Approval Makes Pharming Drug First for Rare Inherited Immune Disease | A rare immunodeficiency discovered just 10 years ago now has its first treatment. The FDA has approved a Pharming Group drug developed to treat activated phosphoinositide 3-kinase delta syndrome, or APDS, a disease that leads to low levels ... |
| 19.03.2023 | Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps | Less than two years after joining the public markets to finance the commercialization of its FDA-cleared digital products, Pear Therapeutics is now joining the ranks of struggling companies exploring “strategic alternatives” that could invo... |
| 15.03.2023 | A new wave of community initiatives from the EU4Youth Alumni Network | With the 2022-2023 cycle of the EU4Youth Alumni Network having already kicked off their work, more than 45 initiatives are underway to make a difference in the lives of young people living in less privileged communities throughout the Easte... |
| 07.03.2023 | New Hemophilia Data Lead FDA to Delay Decision for BioMarin Gene Therapy | Gene therapy for hemophilia A patients in the U.S. will have to wait. The FDA needs more time to review data from BioMarin Pharmaceuticals, and the agency told the company it won’t be able to issue a regulatory decision by the end of March.... |
| 07.03.2023 | Flagship Startup Emerges With $50M to Send Drugs to the Right Biologic Address | When you address a letter and send it in the mail, you can be fairly confident it will reach the right place and nowhere else. The same can’t be said for delivering drugs in the body. Even if a molecule is designed to go to a specific biolo... |
| 03.03.2023 | Eli Lilly Places a Small Bet on Confo’s Early-Stage, Non-Opioid Pain Drug | The pain drug market has many products, but there’s still a need for pills with better properties, such as avoiding addiction. Eli Lilly sees potential in the non-opioid pain drug research from Confo Therapeutics and it’s paying $40 million... |
| 28.02.2023 | The reimagining of Regent Hong Kong as a rare harbourfront haven by visionary designer Chi Wing Lo | HONG KONG, Feb. 28, 2023 /PRNewswire/ -- Regent Hong Kong is proud to announce the unveiling of its stunning transformation by world-renowned architect and design visionary, Chi Wing Lo as the hotel opens its room reservations from March on... |
| 24.02.2023 | FDA Halts Fulcrum Trial, the Latest Setback in a Week of Sickle Cell Stumbles | A Fulcrum Therapeutics clinical trial testing a potential sickle cell disease drug has been paused by the FDA. With the clinical hold on the early-stage study, Fulcrum becomes the fourth company this week with a stalled sickle cell program.... |
| 17.02.2023 | Moderna Flu Vax Prompts Response to More Common Strains, But Misses in Influenza B | A Moderna messenger RNA vaccine for influenza now has preliminary data from a pivotal study showing the shot prompted a strong immune response to the more common strains of the virus but fell short against less common strains.
The results r... |
| 15.02.2023 | MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies | A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its... |
| 15.02.2023 | Dynatrace broadly expands tools for cloud observability analysis
Beyond human scale
Real-time prediction
Show your support for our mission by joining our Cube Club and Cube Event Community of exper... | Infrastructure observability vendor Dynatrace Inc. today is enhancing the Grail data analytics platform to support metrics, distributed traces and multicloud topology and dependencies in addition to the log and business event support that w... |
| 13.02.2023 | Frequency Therapeutics Regenerative Med for Hearing Loss Fails Again in Phase 2 | An experimental regenerative therapy that Frequency Therapeutics was developing to treat a form of hearing loss has failed to beat a placebo in a clinical trial for the second time in two years, results that led the biotech company to annou... |
| 07.02.2023 | NetApp announces new portfolio of storage programs and flash storage for data centers
Flash storage
Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Jo... | Data storage company NetApp Inc. today announced a new portfolio of storage programs and a line of flash storage for modern data centers.
The new portfolio of storage programs, NetApp Advance, has been designed to help customers cost-effect... |
| 05.02.2023 | S.H.Figuarts Celebrates Its 15th Anniversary With A New Event In Akihabara | 'Super Mario' received some amazing S.H.Figuarts a while back.Ollie Barder |
| 03.02.2023 | State Route 7 in the Town of Hoosick, Rensselaer County, Reopens, Detour Lifted | Contact: Bryan Viggiani, (518) 457-6400
Release Date: February 03, 2023 State Route 7 in the Town of Hoosick, Rensselaer County, Reopens, Detour Lifted
DOT and Contractor Forces Installed New Culvert and Reopened Road in Three Weeks Followi... |
| 17.01.2023 | NC DMVA Honors 108-year-old NC World War II Veteran and Montford Point Marine | FOR IMMEDIATE RELEASE
Date: Tuesday, January 17, 2023
Contact: Tammy Martin
Office: 984-292-3255
Cell: 984-480-6256 tammy.martin@milvets.nc.gov
NC DMVA Honors 108-year-old NC World War II Veteran
and Montford Point Marine
Cosmas D. Eaglin, ... |
| 12.01.2023 | Roche Influenza Antiviral Gets European Commission Approval for Young Kids | The influenza season continues to drive new cases and hospitalizations, but clinicians in Europe now have a new tool to try to stop the virus in children. A Roche influenza antiviral drug for adults and adolescents is now approved for those... |
| 07.01.2023 | Jack Ma, who disappeared from public view in 2020, has resurfaced in Thailand. Here's how the Alibaba and Ant Group founder got started and amassed a huge fortune. | Jack Ma, the billionaire founder of Alibaba and Ant Group, resurfaced in Thailand on Friday.
Ant Group said Ma will give up control of the fintech company amid closer scrutiny from Beijing.
He grew up poor and faced multiple job rejections ... |
| 06.01.2023 | Serious Side Effect Sidelines Gene-Edited Sickle Cell Therapy from Graphite Bio | Graphite Bio’s ambitions to use gene-editing to cure sickle cell disease have hit a setback. The first patient dosed with the experimental therapy has developed a serious blood complication, leading the company to pause the clinical trial.
... |
| 05.01.2023 | Tumor-Zapping Device Scores in Pivotal Study, Sends Shares of Novocure Soaring | Combination therapies are a mainstay of cancer care, the idea being that treatments that work in different ways can together offer patients better and longer lasting effects. Scientists have successfully tested therapeutic pairings that inc... |
| 29.12.2022 | NC DMVA Awards Asiatic-Pacific Campaign Medal to NC World War II Veteran 77 Years After Release as a POW | FOR IMMEDIATE RELEASE
Date: Thursday, December 27, 2022
Contact: Tammy Martin
Office: 984-292-3255
Cell: 984-480-6256 tammy.martin@milvets.nc.gov
NC DMVA Awards Asiatic-Pacific Campaign Medal to NC World War II Veteran 77 Years After Releas... |
| 12.12.2022 | Chrome’s “Manifest V3” plan to limit ad-blocking extensions is delayed | Enlarge
Isaac Bowen / Flickr reader comments 140 with 0 posters participating
Share this story
Share on Facebook
Share on Twitter
Share on Reddit
For several years now, Google has wanted to kill Chrome's current extension system in favor of... |
| 07.12.2022 | Entact Bio Emerges With $81M to Play Matchmaker to Protein-Enhancing Drugs | Small molecules are a mainstay of drug therapy, many of them working by targeting a protein and blocking it. A newer but still experimental approach leads to the degradation of disease-causing proteins. Research has revealed new insights in... |
| 30.11.2022 | Eisai Alzheimer’s Drug Data Show Slowing of Decline But Safety Questions Linger | Eisai now has the most detailed look yet at the clinical trial data for its Alzheimer’s disease drug lecanemab, with results showing reductions in telltale disease indicators and a slowing of clinical decline. But the results come amid rece... |
| 28.11.2022 | CinCor Hypertension Drug Flunks Study, But the Biotech Still Sees a Phase 3 Path | A CinCor Pharma drug intended to offer a novel alternative to currently available hypertension treatments has failed a Phase 2 study. Nevertheless, CinCor points to better results in a pre-specified subgroup of patients representative of ma... |
| 20.11.2022 | Acrivon Nets $100M for Protein Tech That Picks Patients for Targeted Cancer Meds | For targeted cancer therapy to work, it’s not enough to identify the right targets to hit with a drug. Just as important is selecting the patients appropriate for a given therapy. Scientists at Acrivon Therapeutics say their approach brings... |
| 18.11.2022 | MDE honors student artists at 21st Annual ‘Rethink Recycling’ Sculpture Contest | MDE honors student artists at 21st Annual ‘Rethink Recycling’ Sculpture Contest
Suitland High’s Jones wins top prize; Annual awards promote recycling, creativity among students
BALTIMORE, MD (November 18, 2022) – Samadhi Aurelia Jones, a st... |
| 04.11.2022 | For Neuro Biotech Lusaris, Depression Therapy Starts by Lifting the Tongue | Depression can be treated by many drugs, but for many patients the available therapies just aren’t good enough. Treatment-resistant depression remains an unmet medical need and psychedelic compounds make up a growing area of research in the... |
| 02.11.2022 | Alkermes Weighs Splitting Off Cancer Biz as Separate, Publicly Traded Company | Alkermes has a portfolio of commercialized neuroscience products and a pipeline that spans both neuroscience and cancer. The drugmaker is now exploring the possibility of splitting off its cancer business as an independent, publicly traded ... |
| 20.10.2022 | Caritas Internationale Freiwilligeneinsätze and Ban Ki-moon Centre for Global Citizens partner for work on SDGs | BKMC CEO Monika Froehler and IFE CEO Martin Frick
BKMC CEO Monika Froehler, Co-chair Heinz Fischer, IFE CEO Martin Frick, IFE SG Andreas Knapp
BKMC CEO Monika Froehler and IFE CEO Martin Frick Signing
Promoting the effective implementation ... |
| 18.10.2022 | Eli Lilly’s $487M Akouos buyout expands its gene therapy scope to hearing loss | Eli Lilly hasn’t been a major player in genetic medicines but a new acquisition gives the pharmaceutical giant the opportunity to develop the first gene therapy for hearing loss. Lilly has agreed to acquire Akouos in a $487 million deal tha... |
| 17.10.2022 | NGM Bio’s Merck-partnered drug for vision loss disorder flunks Phase 2 test | After NGM Biopharmaceuticals’ most advanced internal program flunked a mid-stage study last year, the biotech said it would shift its focus to drug candidates covered by a partnership with Merck, including an antibody in clinical developmen... |
| 16.10.2022 | Cancer drug biotech Enliven shifts to reverse to move forward as a public company | Drugs from a class called tyrosine kinase inhibitors have become standard treatments for some cancers, but the improved survival of patients taking these medicines introduces a new problem. As patients live longer, many decide they no longe... |
| 10.10.2022 | DATCP Secretary Romanski Joins Gov. Evers in Thanking Wisconsin's Farmers | FOR IMMEDIATE RELEASE: October 10, 2022
Contact: Sam Otterson, Communications Director, (608) 334-0220, Sam.Otterson@wisconsin.gov
Download PDF
Editor's note: A photo of Gov. Evers and Secretary Romanski can be found here.
A commentary by ... |
| 06.10.2022 | Versant-founded biotech Nested hatches with $90M and new take on cancer drugs | Understanding the role of certain proteins and mutations has paved the way for many cancer therapies, but in some cases knowing the target and its role is not enough for scientists to be able to find a way to drug it. Cancer drug research c... |
| 06.10.2022 | California dreamin’: A VC firm’s vision for West Coast-focused biotech investment | Bay Area versus Boston/Cambridge is one biotech debate that never ends. Each region has its merits, but San Francisco-based venture capitalist Heath Lukatch says one strike against the Bay is the lack of VC money for early-stage biotechs re... |
| 30.09.2022 | Chrome’s new ad-blocker-limiting extension platform will launch in 2023 | Enlarge
Isaac Bowen / Flickr reader comments 232 with 131 posters participating
Share this story
Share on Facebook
Share on Twitter
Share on Reddit
Google's journey toward Chrome's "Manifest V3" has been happening for four years n... |
| 30.09.2022 | Report finds insiders are a bigger data exposure risk than most executives think
Most cases are accidental
Show your support for our mission by joining our Cube Club and Cube Event Community of expe... | A record 47 million American quit their jobs voluntarily in 2021, and apparently many took sensitive information with them.
That’s the conclusion that emerges from a new report by data detection and response firm Cyberhaven Inc. The company... |
| 28.09.2022 | Eisai, Biogen beat expectations with data that support Alzheimer’s drug approval | An Alzheimer’s disease drug from partners Eisai and Biogen now has data from a pivotal study showing it slowed clinical decline from the memory-robbing neurodegenerative disorder, positive preliminary results that bolster the amyloid-cleari... |
| 26.09.2022 | Prime Medicine spells out IPO plans for ‘word processor’ of gene editing | Gene-editing research is striving for more precise approaches, aiming to avoid off-target edits that spark problems elsewhere in the genome. Prime Medicine aims to offer such precision along with the potential to address a wider range of ge... |
| 21.09.2022 | FDA finally signs off on Fennec Pharma drug for chemo-caused hearing loss in kids | Successfully treated childhood cancer often comes with a tradeoff: irreversible chemotherapy-induced hearing loss that can be managed only with lifelong hearing aids or a cochlear implant. Children undergoing cancer treatment now have a dru... |
| 21.09.2022 | 2,075 Seedlings Planted for the Harriet Tubman Bicentennial Tree Planting | TOWNSEND, Del. (September 21, 2022) – On September 17, over 100 volunteers planted 2,075 trees at the Blackbird State Forest for the Harriet Tubman Bicentennial Tree Planting. This initiative will provide scenic beauty, enhance wildlife hab... |
| 14.09.2022 | Penn spinout Capstan aims for next cell therapy frontier: in vivo cell engineering | University of Pennsylvania scientists who pioneered advances in cell therapy and messenger RNA have unveiled a new venture aiming to bring cell-based therapies into a new frontier: the engineering of these treatments inside the patient. Cap... |
| 25.08.2022 | Stanford spinout 3T Bio snags $40M for immunotherapies targeted to solid tumors | The dominant challenge for developing targeted cancer therapies is finding the right target. Drug hunters look for a protein that’s abundant on cancer cells but also absent on healthy cells, so that the therapy’s effect is concentrated on t... |
| 10.08.2022 | Delaware Sends Wildfire Crew to Northern California | The 2022 DES1 Diamond State Wildfire Crew: (Left to Right, Front to Back): Dave Pro of Newark and Bill Seybold of Dover; Adam Keever of Newark, Eddie Boyer of Frederica, Justin Sauble of Smyrna, Sam Topper of Federalsburg, MD, and Jim Charn... |
| 19.07.2022 | Gundam Universe Nu Gundam Toy Review: The Most Popular Gundam Gets A Special Comic-Con Variant | This Gundam Universe figure will be avaiable to buy at this year's San Diego Comic Con. Ollie Barder |
| 14.07.2022 | CBP Announces Opening of New Temporary Processing Facility in Eagle Pass, Texas | EAGLE PASS, Texas — U.S. Customs and Border Protection today announced the opening of a new soft-sided facility in Eagle Pass, Texas. The facility’s primary purpose is to safely and expeditiously process individuals in U.S. Border Patrol cu... |
| 11.07.2022 | How remote work is changing tech pay: Seattle startup comp equals Silicon Valley, study says | From Space Needle to Golden Gate and beyond, U.S. startup pay is becoming more uniform, a recent study says. (Photos by Kevin Lisota, GeekWire; and Mark Gunn, via Flickr, Creative Commons 2.0)
Remote work is equalizing tech startup pay acro... |
| 01.07.2022 | FWC begins removal of derelict vessels from Levy County | Photos available: https://flic.kr/s/aHBqjzVCz2
The Florida Fish and Wildlife Conservation Commission (FWC) announced today that a total of 12 derelict vessels will be removed from the waterways of Levy County.
There are five vessels to be r... |
| 16.06.2022 | Wyoming National Guard partners with Laramie County Shooting Sports Complex for community project | Sunday marked the completion of a new 300-yard berm at the Laramie County Shooting Sports Complex in Cheyenne. The lane expands on the existing ones at the complex. Soldiers of the 133rd Engineer Company of the Wyoming Army National Guard, ... |
| 31.05.2022 | Memorial Day in Utah 2022 | Governor Spencer J. Cox and Senator Mitt Romney shared short remarks at a special Memorial Day ceremony at the Utah State Capitol on Monday, May 30th. Also in attendance to show their respect for the men and women who have given their lives... |
| 17.05.2022 | Governor Carney Honors Four Century Farm Families, 2022 Marks 35th Year of Delaware Century Farm Program | Note: Pictures are available on Flickr.
DOVER, Del. (May 16, 2022) – Governor Carney, Deputy Secretary of Agriculture Nikko Brady, and state legislators honored four Delaware farm families for their commitment to keeping farmland within the... |
| 12.05.2022 | CIQ raises $26M to promote free alternative to Red Hat Linux
Show your support for our mission by joining our Cube Club and Cube Event Community of experts. Join the community that includes Amazon We... | Ctrl IQ Inc., which does business as CIQ, said today it has raised a $26 million early-stage funding round to advance an alternative to Red Hat Inc.’s Enterprise Linux operating system.
The Series A infusion brings the company’s total finan... |
| 06.05.2022 | Gov. Carney celebrates 150th Arbor Day in Rehoboth Beach | Promotes his “Tree for Every Delawarean Initiative” to Plant One Million Trees
Hi-Resolution Photos: Delaware Forest Service Flickr
REHOBOTH BEACH, Del. (May 6, 2022) – Governor John C. Carney, Jr. celebrated the 150th Anniversary of Arbor ... |
| 06.05.2022 | Gov. Carney celebrates 150th Arbor Day in Rehoboth Beach | Promotes his “Tree for Every Delawarean Initiative” to Plant One Million Trees
Photos at Delaware Forest Service’s Arbor Day Flickr Album
REHOBOTH BEACH, Del. (May 6, 2022) – Governor John C. Carney, Jr. celebrated the 150th Anniversary of ... |
